Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Liang

Showing results (521-530 of 660) with videos related to

Pageof 66
Sort By:
Surgery|May 15, 2025
Risk assessment of lymph node metastasis in early gastric cancer patients with vagus nerve-preserving gastrectomy: A multiple centers potential analysis in ChinaXinyu Wang, Xiangyu Wang, Qi You, et al.
Frontiers in Oncology|July 26, 2021
Intraperitoneal Chemotherapy Using Fluorouracil Implants Combined With Radical Resection and Postoperative Adjuvant Chemotherapy for Stage III Gastric Cancer: A Multi-Center, Randomized, Open-Label, Controlled Clinical StudyYan Xu, Rupeng Zhang, Chunfeng Li, et al.
Cancer Management and Research|April 8, 2020
A Preliminary Study on the Establishment of the PDTX ModelYong Liu, Yan-Ping Zhu, Ming-Zhi Cai, et al.
Nature|August 1, 2014
Clonal evolution in breast cancer revealed by single nucleus genome sequencingYong Wang, Jill Waters, Marco L Leung, et al.
Cancer Cell|October 7, 2014
Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitorsLydia W T Cheung, Shuangxing Yu, Dong Zhang, et al.
BMC Cancer|March 27, 2026
Study protocol for hyperthermic intraperitoneal chemotherapy in the treatment of locally advanced gastric cancer after laparoscopic or robotic Gastrectomy with D2 lymphadenectomy: a phase III multicentre prospective randomized controlled clinical trial (HIPEC-09)Xiaodong Liu, Yulong Tian, Shougen Cao, et al.
Breast Cancer Research : BCR|January 29, 2016
p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancerEmily Powell, Jiansu Shao, Yuan Yuan, et al.
The Journal of Clinical Investigation|November 5, 2019
A-to-I-edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosisXiaoyan Xu, Yumeng Wang, Kamalika Mojumdar, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 1, 2022
Stellettin B Sensitizes Glioblastoma to DNA-Damaging Treatments by Suppressing PI3K-Mediated Homologous Recombination RepairXin Peng, Shaolu Zhang, Yingying Wang, et al.
Cell Reports|April 5, 2018
Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer TypesZhongqi Ge, Jake S Leighton, Yumeng Wang, et al.
Pageof 66

Showing results (521-530 of 660) with videos related to

Sort By:
Pageof 66
Surgery|May 15, 2025
Risk assessment of lymph node metastasis in early gastric cancer patients with vagus nerve-preserving gastrectomy: A multiple centers potential analysis in ChinaXinyu Wang, Xiangyu Wang, Qi You, et al.
Frontiers in Oncology|July 26, 2021
Intraperitoneal Chemotherapy Using Fluorouracil Implants Combined With Radical Resection and Postoperative Adjuvant Chemotherapy for Stage III Gastric Cancer: A Multi-Center, Randomized, Open-Label, Controlled Clinical StudyYan Xu, Rupeng Zhang, Chunfeng Li, et al.
Cancer Management and Research|April 8, 2020
A Preliminary Study on the Establishment of the PDTX ModelYong Liu, Yan-Ping Zhu, Ming-Zhi Cai, et al.
Nature|August 1, 2014
Clonal evolution in breast cancer revealed by single nucleus genome sequencingYong Wang, Jill Waters, Marco L Leung, et al.
Cancer Cell|October 7, 2014
Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitorsLydia W T Cheung, Shuangxing Yu, Dong Zhang, et al.
BMC Cancer|March 27, 2026
Study protocol for hyperthermic intraperitoneal chemotherapy in the treatment of locally advanced gastric cancer after laparoscopic or robotic Gastrectomy with D2 lymphadenectomy: a phase III multicentre prospective randomized controlled clinical trial (HIPEC-09)Xiaodong Liu, Yulong Tian, Shougen Cao, et al.
Breast Cancer Research : BCR|January 29, 2016
p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancerEmily Powell, Jiansu Shao, Yuan Yuan, et al.
The Journal of Clinical Investigation|November 5, 2019
A-to-I-edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosisXiaoyan Xu, Yumeng Wang, Kamalika Mojumdar, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 1, 2022
Stellettin B Sensitizes Glioblastoma to DNA-Damaging Treatments by Suppressing PI3K-Mediated Homologous Recombination RepairXin Peng, Shaolu Zhang, Yingying Wang, et al.
Cell Reports|April 5, 2018
Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer TypesZhongqi Ge, Jake S Leighton, Yumeng Wang, et al.
Pageof 66